Delivery Order SPE2DB24D8001-SPE2DB25FKZFH
Award Date
2/14/25
Potential Completion Date
2/18/25
Potential Value
$8.1K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $9,456.99 to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, with an ultimate completion date of October 18, 2024. This award is part of Dakota Drug, Inc.'s Indefinite Delivery Contract (IDC) SPE2DB24D8001 valued at $999,999,999.00, which allows the company to provide a comprehensive range of...
The Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of STELARA 90 MG/ML syringes. The $8,236.05 contract has a performance period through January 16, 2025 and is not a set-aside award. Dakota Drug, Inc. is the prime contractor and this award is part of the DLA Troop Support Medical's ECAT Generation V Program, a large Indefinite Delivery Contract (IDC) valued at...
This is a $11,114.44 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a small disadvantaged business, for the supply of STELARA 90 MG/ML syringes. The contract has an ultimate completion date of May 2, 2024. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. Department of Defense, with a significant single-award Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of STELARA 90 MG/ML syringes. The $8,187.08 firm-fixed price award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00. This IDC allows Dakota Drug, Inc. to provide a wide range of pharmaceutical products, medical supplies, and healthcare...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $20,476.24 firm fixed-price delivery order is for the pharmaceutical product STELARA 90 MG/ML SYRINGEML, with a period of performance through February 27, 2024. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of the DLA Troop Support Medical's...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of STELARA 90 MG/ML SYRINGEML. The contract, valued at $11,903.19, has a completion date of February 1, 2024, and does not have a set-aside designation. Dakota Drug, Inc. is a for-profit subchapter S corporation that has been providing a comprehensive range of pharmaceutical products, medical supplies,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $12,993.62 firm fixed-price contract is for the delivery of STELARA 90 MG/ML syringes, with a performance period ending on May 17, 2023. The contract is not set-aside and is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) SPE2DB24D8001 valued at $999,999,999.00, which allows the company to...
This federal contract award, identified as SPE2DX15D8002|SPE2DX23F2XL4, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to the prime contractor Dakota Drug, Inc. The $8,963.87 firm fixed-price delivery order is for the procurement of STELARA 90 MG/ML syringes, a pharmaceutical product. The contract has a performance period extending through May 18, 2023 and is not a set-aside award. Dakota Drug, Inc. is a self-certified small disadvantaged business that...
This federal contract award, with ID SPE2DX15D8001|SPE2DX24FBQKX, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $11,091.23 firm fixed-price delivery order is for the supply of STELARA 90 MG/ML SYRINGEML pharmaceutical products. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, as part of the DLA Troop Support Medical's...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $19,196.40, is for the delivery of STELARA 90 MG/ML SYRINGEML medical supplies. The contract is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC is under the DLA Troop Support...